Atopic dermatitis therapy is currently undergoing a revolution that promises to treat patients of all ages who are suffering from every aspect of the disease—from rashes, itch and sleep disturbances, to secondary effects, like anxiety and depression.
Though still considered controversial, several evolving treatment and management plans for primary cutaneous melanoma are making their way into the mainstream and challenging more traditional approaches.
New joint AAD-NPF guidelines consider the quality-of-life impact of pediatric psoriasis as well as comorbidity risks in this patient population.
Dermatologists should engage in collaborative efforts to guide pharmaceutical companies as they develop drugs needed for the continued excellence of the specialty.
Sun Dermatology is launching an acne awareness advertising campaign, Take on Acne, that focuses on the skin condition’s impact on teens and young adults’ quality of life.
New York city cosmetic dermatologist Michele Green, M.D., says having a muscle stimulating device can boost a practice’s bottom line but that’s not a given.
Introducing The Mainstream Patient, a weekly glimpse into what your patients may be reading in the media about skin health.
Cosmetic physician Tahl Humes, D.O., offers recommendations for doctors who are considering investing in body toning devices.
Positive phase 3 results from two clinical trials suggests that Sol-Gel’s novel 5% microencapsulated benzoyl peroxide cream may offer quick, effective relief for patients with papulopustular rosacea.
Sun Pharma introduces a lower dose isotretinoin capsule in the U.S. for the treatment of severe recalcitrant nodular acne.